RemSleep Holdings (RMSL) Cash from Operations Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.04% |
| Sep 30, 2025 | -24.03% |
| Jun 30, 2025 | 1.79% |
| Mar 31, 2025 | -7.25% |
| Dec 31, 2024 | -11.13% |
| Sep 30, 2024 | -39.32% |
| Jun 30, 2024 | -21.93% |
| Mar 31, 2024 | -21.98% |
| Dec 31, 2023 | -51.07% |
| Sep 30, 2023 | -46.58% |
| Jun 30, 2023 | -52.26% |
| Mar 31, 2023 | -39.51% |
| Dec 31, 2022 | -64.06% |
| Sep 30, 2022 | -58.76% |
| Jun 30, 2022 | -119.08% |
| Mar 31, 2022 | -59.26% |
| Dec 31, 2021 | 5.52% |
| Sep 30, 2021 | -87.97% |
| Jun 30, 2021 | -115.49% |
| Mar 31, 2021 | -19.40% |
| Dec 31, 2020 | -36.17% |
| Jun 30, 2020 | -32.13% |
| Mar 31, 2020 | -17.99% |
| Dec 31, 2019 | 0.42% |
| Dec 31, 2018 | -54.48% |
| Sep 30, 2018 | -44.42% |
| Jun 30, 2018 | 46.85% |
| Mar 31, 2018 | -162.55% |
| Dec 31, 2017 | 18.45% |
| Sep 30, 2017 | -14.89% |
| Jun 30, 2017 | 71.45% |
| Mar 31, 2017 | -2.41% |
| Dec 31, 2016 | -10.90% |
| Sep 30, 2016 | -35.53% |
| Jun 30, 2016 | 42.89% |
| Mar 31, 2016 | -6.55% |
| Dec 31, 2015 | 41.24% |